Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
MORRISVILLE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ:LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 10,000 shares of Liquidia’s common stock to newly hired non-executive employees under the Liquidia Corporation 2022 Inducement Plan (the “Inducement Plan”). Each stock option was granted as an inducement material to the grantee’s acceptance of employment with Liquidia (or one of its subsidiaries) as a component of the grantee’s employment compensation in accordance with Nasdaq Listing Rule 5635(c)(4).
Related news for (LQDA)
- Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
- U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
- Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
- Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
- District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia